Graph Convolutional Network-Based Screening Strategy for Rapid Identification of SARS-CoV-2 Cell-Entry Inhibitors
Peng Gao(Army Medical University), Min Shen(Kaili University), Yihong Ye(National Institute of Diabetes and Digestive and Kidney Diseases), Qi Zhang(Northeast Agricultural University), Miao Xu(National Institutes of Health), Catherine Z. Chen(National Institutes of Health), Hui Guo(First Affiliated Hospital of Xi'an Jiaotong University), Wei Zheng(Liaoning Cancer Hospital & Institute)
Cited by 8
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225